Madison, WINCT07454733Now EnrollingIRB Ready

Amyotrophic Lateral Sclerosis (ALS) Clinical Trial in Madison, WI

Access cutting-edge amyotrophic lateral sclerosis (als) treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.

Sponsored by Trustees of Dartmouth College

Quick Self-Assessment

See if you qualify for this Madison location

Preparing your pre-screening questions…

Expert Care in Madison

Access amyotrophic lateral sclerosis (als) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related amyotrophic lateral sclerosis (als) treatment provided free

Apply for This Madison Location

Check if you qualify for this amyotrophic lateral sclerosis (als) clinical trial in Madison, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Madison

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Madison site if eligible
  4. 4Begin participation

About This Amyotrophic Lateral Sclerosis (ALS) Study in Madison

Amyotrophic lateral sclerosis (ALS) is a fatal, rare neurodegenerative disease affecting 30,000 people in the United States. The gold standard of care for people with ALS is multidisciplinary clinics (MDC). In these multidisciplinary clinics, which occur every 3 to 4 months, people with ALS see up to 12 different healthcare providers (e.g., speech therapy, physical therapy, the ALS doctor). These clinics can last from three to five hours, and across these three to five hours people with ALS and their caregivers receive a lot of information that is critical to the care and quality of life for people with ALS. However, this information can be difficult to remember given the large amount of information that is conveyed. The current standard for providing take-home information about the visit is to provide patients with a written after-visit summary and access to their doctor's notes about the visit, typically through the patient portal. This study tests whether providing participants with video recordings of their MDC visits improves their quality of life and the quality of life of their caregivers. The study will enroll 400 pairs of people with ALS and their caregivers from eight different sites in the United States. Half of the participants in the study will receive their after-visit summary notes (the NOTES condition) and the other half of the participants will receive both their summary notes, but will also receive video recordings of their MDC visits that they can watch on their own at home (the VIDEO condition). The study will last for 12 months, with participants receiving NOTES or VIDEO at each of their regularly-scheduled MDCs during the 12 months. The study will test whether caregiver and patient participants in the VIDEO condition experience better quality of life than those in the NOTES condition at 1 month, 6 months, and 12 months from study enrollment. The results of this study will help determine what is the most effective approach to communicating MDC information to people with ALS and their caregivers.

Sponsor: Trustees of Dartmouth College

Who Can Participate

Inclusion Criteria

for People with ALS:
Diagnosis of ALS by either El- Escorial or Gold Coast Criteria
≥18 years of age
Plan to attend MDC visits for 12 months
Speak English or Spanish
Presence of a caregiver (defined as someone who assists with care) who is also participating in the VITALS trial
Projected life expectancy of at least 12 months as determined by the site investigator.

Exclusion Criteria

for People with ALS:
Unable or unwilling to provide informed consent or follow study procedures
Significant cognitive impairment, clinical dementia, or unstable psychiatric illness (including, but not limited to, psychosis, active suicidal ideation, suicide attempt, or untreated major depression) as determined by the site investigator
Current pregnancy based on participant self-report;
Unable to access the internet;
Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
Do not wish to create a patient portal account, if they do not already have one;
Uncorrected hearing or visual impairment that would impair the ability to view video recordings;
Incarcerated. Inclusion Criteria for Caregivers:
Agree to their identified role as a caregiver of a patient with ALS participating in the VITALS trial;
Speak English or Spanish;
≥18 years of age. Exclusion Criteria for Caregivers:
Unable or unwilling to provide consent or follow study procedures;
Unable to access the internet;
Do not have access to a personal or shared email and are not interested in creating a personal or shared email;
Uncorrected hearing or visual impairment;
Professional caregiver for the patient;
Incarcerated.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Madison?

Yes, this clinical trial (NCT07454733) has an active research site in Madison, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Amyotrophic Lateral Sclerosis (ALS) Treatment Options in Madison, WI

If you're searching for amyotrophic lateral sclerosis (als) treatment options in Madison, WI, this clinical trial (NCT07454733) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced amyotrophic lateral sclerosis (als) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all amyotrophic lateral sclerosis (als) clinical trials near you to find additional studies recruiting in your area.

More ALS Trials in Madison, WI

See all als clinical trials recruiting in Madison — not just this study.

Browse ALS Trials in Madison →

Ready to Join in Madison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Madison, WI